Alpine Global Management, LLC Biomarin Pharmaceutical Inc Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $186,372 - $230,918
2,504 New
2,504 $206,000
Q2 2023

Aug 06, 2024
BUY
$86.68 - $100.3 $806,124 - $932,790
9,300 New
9,300 $806,000
Q2 2023

Nov 21, 2023
BUY
$86.68 - $100.3 $806,124 - $932,790
9,300 New
9,300 $806,000
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $806,124 - $932,790
9,300 New
9,300 $806,000

Others Institutions Holding BMRN

# of Institutions
635
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email